Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: an individual patient data pairwise and network meta-analysis of six randomized trials and 11 473 patients
Tullio Palmerini(University of Bologna), Gregg W. Stone(Cardiovascular Research Foundation), Philippe Généreux(Morristown Medical Center), Yangsoo Jang(Yonsei University), Deepak L. Bhatt(Brigham and Women's Hospital), Umberto Benedetto(University of Oxford), Martine Gilard(Centre Hospitalier Régional Universitaire de Brest), Alaide Chieffo, Antonio Colombo(Memorial Hermann), Marco Valgimigli(University of Bern), Maria Pufulete(University of Bristol), Alexandre Abizaid(Instituto Dante Pazzanese de Cardiologia), Diego Sangiorgi(University of Bologna), Hyo‐Soo Kim(Seoul National University), Myeong‐Ki Hong(Ulsan College), Gianni D. Angelini(University of Bristol), Giuseppe Biondi‐Zoccai(Sapienza University of Rome), Diego Della Riva(University of Bologna), Fausto Feres(Instituto Dante Pazzanese de Cardiologia), Maria Letizia Bacchi Reggiani, Marie‐Claude Morice(Institut Cardiovasculaire Paris Sud), Kyung Woo Park(Boston University), Jonathon White(NewYork–Presbyterian Hospital), Byeong‐Keuk Kim(Ewha Womans University)
Cited by 200
Related Papers
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2018|6.3k
A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization
|New England Journal of Medicine|2002|4k
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
|New England Journal of Medicine|2018|3.5k
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
|New England Journal of Medicine|2018|3.2k